Composition: Disodium creatine phosphate (as tetrahydrate)
Form: Powder for solution for injection
Indications: Acute myocardial infarction, chronic heart failure, heart surgery, acute cerebrovascular accident (as part of complex therapy), skeletal muscle overstrain.
Contraindications: Hypersensitivity to the drug components.
Dosage: IV: 2 g as a bolus, then 5 g via infusion; in CHF — 1 g twice daily for 14 days, then 0.5–1 g/day; for surgery — 2 g before surgery, then infusion during operation; for IM injection — dissolve in 4 ml with 40 mg lidocaine.
Side effects: Rare — allergic reactions.
Interactions: Compatible with digoxin, furosemide, dopamine, carnitine, citicoline, verapamil, etc. (stable for 3–5 hours).
Warnings: Does not replace cardiokinetic therapy. Do not use glucose solution in diabetic patients. Do not use after the expiration date.
Age restrictions: 18+
Pregnancy: No data on pregnancy; use with caution when necessary.
Manufacturer: Hebei Tiancheng Pharmaceutical Co., Ltd, China
Storage conditions: Store below 20°C, in a dark place out of children's reach.
There are no studies available.
❓ How often is Revarton used for myocardial infarction?
💬 On day 1 — 2 g IV bolus, then 5 g IV infusion; following days — 5 g IV daily.
❓ Can it be used during heart surgery?
💬 Yes, it is used before, during, and after surgery, including in cardioplegic solutions.